Patrick Caubel

988 total citations
41 papers, 530 citations indexed

About

Patrick Caubel is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Patrick Caubel has authored 41 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Genetics. Recurrent topics in Patrick Caubel's work include Estrogen and related hormone effects (7 papers), Menopause: Health Impacts and Treatments (6 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Patrick Caubel is often cited by papers focused on Estrogen and related hormone effects (7 papers), Menopause: Health Impacts and Treatments (6 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Patrick Caubel collaborates with scholars based in United States, France and Canada. Patrick Caubel's co-authors include Robert F. Reynolds, Laurent Azoulay, Nancy A Dreyer, Yvon Chitrit, Pilar Lim, Olavi Ylikorkala, Krishan Kumar, Patricia J. Sulak, Robert H. Lane and Pharath Lim and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Patrick Caubel

35 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Caubel United States 14 125 124 96 83 78 41 530
Kui Huang United States 13 77 0.6× 30 0.2× 34 0.4× 14 0.2× 50 0.6× 29 613
Ruben G. Duijnhoven Netherlands 13 16 0.1× 22 0.2× 247 2.6× 232 2.8× 120 1.5× 36 617
Zoé Uhry France 18 74 0.6× 91 0.7× 9 0.1× 26 0.3× 45 0.6× 45 733
Lesley Wise United Kingdom 9 55 0.4× 40 0.3× 52 0.5× 5 0.1× 49 0.6× 12 480
Anushi Shah United States 12 62 0.5× 34 0.3× 15 0.2× 14 0.2× 14 0.2× 26 793
Diana T. Chingos United States 8 31 0.2× 19 0.2× 58 0.6× 14 0.2× 77 1.0× 8 516
Mary E. Ritchey United States 13 15 0.1× 34 0.3× 41 0.4× 12 0.1× 97 1.2× 32 564
Panpan Wang China 9 84 0.7× 242 2.0× 16 0.2× 10 0.1× 53 0.7× 19 663
Elvira D’Andrea United States 22 257 2.1× 177 1.4× 77 0.8× 15 0.2× 212 2.7× 62 1.1k
Chun Ho Ngai Hong Kong 13 33 0.3× 49 0.4× 51 0.5× 30 0.4× 27 0.3× 15 1.0k

Countries citing papers authored by Patrick Caubel

Since Specialization
Citations

This map shows the geographic impact of Patrick Caubel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Caubel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Caubel more than expected).

Fields of papers citing papers by Patrick Caubel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Caubel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Caubel. The network helps show where Patrick Caubel may publish in the future.

Co-authorship network of co-authors of Patrick Caubel

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Caubel. A scholar is included among the top collaborators of Patrick Caubel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Caubel. Patrick Caubel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koffi, Alain K., et al.. (2025). Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review. Journal of Pharmaceutical Policy and Practice. 18(1). 2550369–2550369.
2.
Beninger, Paul, et al.. (2022). Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey. Clinical Therapeutics. 44(9). 1225–1236. 7 indexed citations
3.
4.
Chen, Yan, et al.. (2020). Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective. Drug Safety. 44(1). 95–105. 10 indexed citations
5.
Stergiopoulos, Stella, et al.. (2019). Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey. Pharmaceutical Medicine. 33(6). 499–510. 18 indexed citations
6.
Reynolds, Robert F., et al.. (2019). Trial designs using real‐world data: The changing landscape of the regulatory approval process. Pharmacoepidemiology and Drug Safety. 29(10). 1201–1212. 142 indexed citations
7.
Hauben, Manfred, Robert F. Reynolds, & Patrick Caubel. (2018). Deconstructing the Pharmacovigilance Hype Cycle. Clinical Therapeutics. 40(12). 1981–1990.e3. 8 indexed citations
8.
Wu, Jasmanda, Wanju S. Dai, Andrew Koren, et al.. (2014). Assessment of Dronedarone Utilization Using US Claims Databases. Clinical Therapeutics. 36(2). 264–272.e2. 7 indexed citations
9.
Pasqualini, Jörge R., Patrick Caubel, Andrew J. Friedman, Jean-Claude Philippe, & Gérard S. Chetrite. (2003). Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 193–198. 15 indexed citations
10.
Ylikorkala, Olavi, Torsten Wahlström, Patrick Caubel, & Rosanne Lane. (2002). Intermittent progestin administration as part of hormone replacement therapy: long‐term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol2 mg combined with constant norethisterone acetate. Acta Obstetricia Et Gynecologica Scandinavica. 81(7). 654–660. 3 indexed citations
11.
Rozenberg, Serge, Patrick Caubel, & Pilar Lim. (2001). Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. International Journal of Gynecology & Obstetrics. 72(3). 235–243. 17 indexed citations
12.
Sl, Corson, Richart Rm, Patrick Caubel, & Pharath Lim. (2000). Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology.. PubMed. 44(6). 279–85. 24 indexed citations
13.
Løbo, Rogerio A., et al.. (2000). A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17β-estradiol on lipid and lipoprotein profiles. American Journal of Obstetrics and Gynecology. 182(1). 41–49. 17 indexed citations
14.
Chitrit, Yvon, et al.. (2000). Absence of flow velocity waveform changes in uterine arteries after bilateral internal iliac artery ligation. American Journal of Obstetrics and Gynecology. 182(3). 727–728. 14 indexed citations
15.
Sulak, Patricia J., Patrick Caubel, & Robert H. Lane. (2000). Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy.. PubMed. 44(6). 286–96. 20 indexed citations
16.
17.
Chitrit, Yvon, et al.. (2000). Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. BJOG An International Journal of Obstetrics & Gynaecology. 107(4). 501–507. 41 indexed citations
18.
Caubel, Patrick, et al.. (1997). Valeur prédictive de la prolactine cervico-vaginale dans l'évaluation du risque d'accouchement prématuré.. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 26(1). 95–99. 2 indexed citations
19.
Caubel, Patrick, et al.. (1990). Cancer de l'endomètre: épidémiologie, histologie, moyens diagnostiques. La Revue du praticien. 40(1). 31–35. 1 indexed citations
20.
Blondon, J, et al.. (1989). [Diagnosis and treatment of digestive endometriosis].. PubMed. 43(4). 265–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kui Huang Breakdown of academic impact, for papers by Ruben G. Duijnhoven Breakdown of academic impact, for papers by Zoé Uhry Breakdown of academic impact, for papers by Lesley Wise Breakdown of academic impact, for papers by Anushi Shah Breakdown of academic impact, for papers by Diana T. Chingos Breakdown of academic impact, for papers by Mary E. Ritchey Breakdown of academic impact, for papers by Panpan Wang Breakdown of academic impact, for papers by Elvira D’Andrea Breakdown of academic impact, for papers by Chun Ho Ngai
Rankless by CCL
2026